A meta-analysis of the randomized controlled trials for the efficacy of prehospital administration of TXA in trauma patients showed a trend toward lower 30-day mortality and a reduced risk of thromboembolic events [ 41 ].
← all excerpts
Hemostatic agents for prehospital hemorrhage control: a narrative review.
1
—
—